Skip to main content
Main menu
About
Our Mission
Donors
Board of Directors
Advisory Boards
Staff
Careers
Who we are
FAQ
Annual Report
Why New TB Drugs?
Global Pandemic
Inadequate Treatment
Antimicrobial Resistance
Maternal and Child Health
Cycle of Poverty
R&D
Scientific Vision
Pipeline
Discovery
Engaging Communities
Access
Our Commitment
Access in TB Market
Child-friendly medicines
Pretomanid and BPaL
Pathways to Access BPaL
News
Latest News
Publications
Voices of TB
Research Papers
Making an Impact
Donate
Search form
Search
Voices of TB
Videos from the Global Health Community
Featured Videos
Fighting the Oldest Pandemic
Panganai’s Story of #TBCourage
Market Access
Overcoming TB Together
Joi's Story of #TBCourage
Karl Hofmann: Better medicines for children with TB
Thought Leader Series: New TB Drugs for Children: Planning for uptake, maximizing access
Addressing the Large and Messy Private TB Drug Market
TB Alliance 2012: Realizing the Promise
Change Starts Here
Past, Present, and Future of Estimating Pediatric TB Burden
Filter by Subject
Community Engagement
(24)
CPTR
(5)
Drug-resistance
(34)
Market Access
(8)
Patient Stories
(30)
Pediatric TB
(21)
Resource Mobilization
(9)
TB-HIV
(6)
TB Research
(32)
TB Awareness
(39)
TB Alliance
(34)
TB Advocacy
(31)
